Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.
about
Two different point mutations in ABL gene ATP-binding domain conferring primary imatinib resistance in a chronic myeloid leukemia (CML) patient: A case reportOmacetaxine: a protein translation inhibitor for treatment of chronic myelogenous leukemiaNovel therapies for patients with chronic myeloid leukemia.Homoharringtonine: a new treatment option for myeloid leukemia.A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia.Homoharringtonine for the treatment of chronic myelogenous leukemia.Homoharringtonine/omacetaxine mepesuccinate: the long and winding road to food and drug administration approvalHomoharringtonine and omacetaxine for myeloid hematological malignancies.NS-187 (INNO-406), a Bcr-Abl/Lyn dual tyrosine kinase inhibitor.Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development.Omacetaxine mepesuccinate (synribo) - newly launched in chronic myeloid leukemia.Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia.Omacetaxine mepesuccinate in chronic myeloid leukemia.A safety evaluation of omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia.Homoharringtonine as a backbone drug for the treatment of newly diagnosed pediatric acute myeloid leukemia: a report from a single institution in China.Imatinib-resistant CML cells have low ENT activity but maintain sensitivity to gemcitabine.Dual inhibition of ras and bcr-abl signalling pathways in chronic myeloid leukaemia: a phase I/II study in patients in complete haematological remission.Self-inactivating lentiviral vectors resist proviral methylation but do not confer position-independent expression in hematopoietic stem cells.Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products.Omacetaxine mepesuccinate for the treatment of leukemia.
P2860
Q24800045-95D44F78-7E35-4D3D-A94A-77BA8390D06EQ33721114-2777A596-1230-4118-BE6F-13C3FF8851CDQ35728742-984D147B-607A-4678-9F93-47984D1DF9BDQ35994823-322AAA19-560F-4C76-8F08-F918A4673CBBQ36612188-FEF0C206-6CBF-4B7A-8175-C7C96310C752Q37123425-39D7BB47-8D68-4F3B-B592-775B6D1E7D81Q37179439-3663BCB8-A132-4A5D-9408-2EA62DE96DA6Q37446279-36EDA3F0-45D6-473F-BD3C-9AE8D2782777Q37574957-2A02AB8D-2810-4084-9AED-A926443755FBQ38088759-67F10FE2-A137-47F6-99A7-EEE82D7F5DA1Q38123196-6A1FC0D1-8B90-41AB-98C2-A3B726F3FA50Q38187115-F39DB00B-2254-4432-A619-AEE8171F271BQ38258641-8EFF9340-2E25-4CA3-BD93-EA505DA9A9F2Q38846325-F6358967-5EEA-48C2-B16D-2F67FDA8057BQ39758498-2B7D0BC9-9FFC-47FE-868F-546DB2BFF811Q39965234-4165AAB1-5A71-4D3C-9AEA-799A65A769A6Q40452878-68A27720-C4DC-4040-ADBF-6AEEF87E310BQ45007190-D6102ECD-12EF-4549-AC41-5D3A9022A3DBQ49887894-315B4C1C-59CA-4D4F-A34D-2065E72896F3Q52892987-D385B8CC-C5B7-4CA1-ADD3-2E16698AAD14
P2860
Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Results of triple therapy with ...... ukemia in early chronic phase.
@en
Results of triple therapy with ...... ukemia in early chronic phase.
@nl
type
label
Results of triple therapy with ...... ukemia in early chronic phase.
@en
Results of triple therapy with ...... ukemia in early chronic phase.
@nl
prefLabel
Results of triple therapy with ...... ukemia in early chronic phase.
@en
Results of triple therapy with ...... ukemia in early chronic phase.
@nl
P2093
P50
P356
P1433
P1476
Results of triple therapy with ...... ukemia in early chronic phase.
@en
P2093
Deborah Thomas
Emil Freireich
Jianqin Shan
Kevin White
Moshe Talpaz
Steven Kornblau
Susie Mallard
P304
P356
10.1002/CNCR.11620
P407
P50
P577
2003-09-01T00:00:00Z